Cerity Partners LLC Takes Position in Doximity, Inc. (NASDAQ:DOCS)

→ Missed NVDA? Buy this AI stock NOW (From Chaikin Analytics) (Ad)

Cerity Partners LLC purchased a new position in shares of Doximity, Inc. (NASDAQ:DOCS - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm purchased 39,218 shares of the company's stock, valued at approximately $1,100,000.

A number of other hedge funds also recently made changes to their positions in DOCS. Sequoia Financial Advisors LLC purchased a new position in Doximity in the fourth quarter valued at approximately $325,000. RFG Advisory LLC purchased a new position in shares of Doximity in the 4th quarter valued at $654,000. Tritonpoint Wealth LLC acquired a new position in shares of Doximity during the 4th quarter valued at $597,000. New York State Teachers Retirement System boosted its position in Doximity by 10.0% during the 4th quarter. New York State Teachers Retirement System now owns 87,381 shares of the company's stock worth $2,450,000 after purchasing an additional 7,969 shares during the period. Finally, Arizona State Retirement System boosted its position in Doximity by 2.6% during the 4th quarter. Arizona State Retirement System now owns 31,950 shares of the company's stock worth $896,000 after purchasing an additional 801 shares during the period. Institutional investors and hedge funds own 87.19% of the company's stock.

Insider Activity

In related news, Director Kira Scherer Wampler sold 2,500 shares of the stock in a transaction dated Monday, April 1st. The shares were sold at an average price of $26.97, for a total transaction of $67,425.00. Following the sale, the director now owns 10,258 shares in the company, valued at $276,658.26. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 39.40% of the company's stock.


Analysts Set New Price Targets

Several equities research analysts have recently weighed in on DOCS shares. JPMorgan Chase & Co. upped their target price on Doximity from $22.00 to $25.00 and gave the stock an "underweight" rating in a research report on Friday, March 15th. Truist Financial increased their price objective on shares of Doximity from $28.00 to $29.00 and gave the company a "hold" rating in a research report on Friday, February 9th. Evercore ISI reissued an "in-line" rating and set a $30.00 target price on shares of Doximity in a research report on Tuesday, April 2nd. Bank of America raised their price target on shares of Doximity from $29.00 to $32.00 and gave the company a "neutral" rating in a report on Tuesday, January 23rd. Finally, SVB Leerink initiated coverage on shares of Doximity in a report on Monday, February 26th. They issued a "market perform" rating and a $32.00 price objective on the stock. Two analysts have rated the stock with a sell rating, ten have assigned a hold rating and two have assigned a buy rating to the stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus price target of $28.82.

Read Our Latest Report on Doximity

Doximity Trading Up 0.6 %

NASDAQ DOCS traded up $0.16 on Monday, hitting $24.79. 885,060 shares of the stock traded hands, compared to its average volume of 1,749,329. The company has a market capitalization of $4.62 billion, a P/E ratio of 37.56, a price-to-earnings-growth ratio of 3.10 and a beta of 1.17. The stock has a 50-day moving average of $27.42 and a 200 day moving average of $26.19. Doximity, Inc. has a twelve month low of $19.71 and a twelve month high of $37.06.

Doximity (NASDAQ:DOCS - Get Free Report) last posted its quarterly earnings results on Thursday, February 8th. The company reported $0.25 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.19 by $0.06. The business had revenue of $135.28 million for the quarter, compared to analyst estimates of $127.46 million. Doximity had a return on equity of 16.08% and a net margin of 29.39%. As a group, equities research analysts expect that Doximity, Inc. will post 0.72 earnings per share for the current year.

About Doximity

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

See Also

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

→ The Gold Grab of the Century (From Colonial Metals) (Ad)

Should you invest $1,000 in Doximity right now?

Before you consider Doximity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Doximity wasn't on the list.

While Doximity currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

Featured Articles and Offers

Search Headlines: